Anastasia Traband, MD
Retina Specialist · Wyomissing, PANPI 1851686331
Payments from drug & device makers
Across 156 payments — averaging $26.61 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- AbbVie$1K
- Regeneron Healthcare Solutions, Inc.$898
- Genentech USA, Inc.$434
- Tarsus Pharmaceuticals, Inc.$190
- Alimera Sciences, Inc.$175
- Glaukos Corporation$175
- plus $1K from 18 others
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| AbbVie(2 entities) | 47 | $1,212 |
| Regeneron Healthcare Solutions, Inc. | 36 | $898 |
| Genentech USA, Inc. | 24 | $434 |
| Tarsus Pharmaceuticals, Inc. | 2 | $190 |
| Alimera Sciences, Inc. | 6 | $175 |
| Glaukos Corporation | 2 | $175 |
| Astellas Pharma Global Development | 1 | $150 |
| Aerie Pharmaceuticals, Inc. | 3 | $149 |
| Astellas Pharma US Inc | 6 | $119 |
| Alcon | 4 | $83 |
| Bausch & Lomb Americas Inc. | 4 | $82 |
| Eyepoint US, Inc. | 2 | $74 |
| Apellis Pharmaceuticals, Inc. | 3 | $71 |
| Novartis | 4 | $49 |
| Coherus Oncology, Inc. | 1 | $48 |
| Sight Sciences, Inc. | 1 | $45 |
| ANI Pharmaceuticals, Inc. | 2 | $44 |
| Mallinckrodt Hospital Products Inc. | 2 | $43 |
| Genentech, Inc. | 1 | $27 |
| Carl Zeiss Meditec, Inc. | 1 | $17 |
| Amgen | 1 | $17 |
| Kala Pharmaceuticals, Inc. | 1 | $17 |
| Bausch & Lomb, A Division Of Bausch Health US, LLC | 1 | $16 |
| Spark Therapeutics, Inc. | 1 | $13 |
How this compares
$4,151 in reported general payments places this provider in the 60th percentile of 43 retina specialist providers in Pennsylvania.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Other retina specialist in Wyomissing
- Moiz CarimWyomissing$6K
- Tapan PatelWyomissing$3K
- Angela BarberaWyomissing$3K
- Barry MalloyWyomissing$2K
- Albert MaguirePhiladelphia$4.1M
- Joshua GreenePhiladelphia$394K
- Alexander BruckerPhiladelphia$240K
- Tomas AlemanPhiladelphia$190K
- Benjamin KimPhiladelphia$177K
- Jay ChhablaniPittsburgh$70K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.